Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/168103
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Olivan Riera, Mireia | - |
dc.contributor.author | Springer, Jochen | - |
dc.contributor.author | Busquets Rius, Sílvia | - |
dc.contributor.author | Tschirner, Anika | - |
dc.contributor.author | Figueras, Maite | - |
dc.contributor.author | Toledo Soler, Miriam | - |
dc.contributor.author | Fontes de Oliveira, Cibely Cristine | - |
dc.contributor.author | Genovese, Maria Inês | - |
dc.contributor.author | Ventura da Silva, Paula | - |
dc.contributor.author | Sette, Angelica | - |
dc.contributor.author | López-Soriano, Francisco J. | - |
dc.contributor.author | Anker, Stefan | - |
dc.contributor.author | Argilés Huguet, Josep Ma. | - |
dc.date.accessioned | 2020-07-08T12:30:01Z | - |
dc.date.available | 2020-07-08T12:30:01Z | - |
dc.date.issued | 2012-08-21 | - |
dc.identifier.issn | 1743-7075 | - |
dc.identifier.uri | http://hdl.handle.net/2445/168103 | - |
dc.description.abstract | Background and aims: the aim of the present investigation was to examine the anti-wasting effects of theophylline (a methylxantine present in tea leaves) on a rat model of cancer cachexia. Methods: the in vitro effects of the nutraceuticals on proteolysis were examined on muscle cell cultures submitted to hyperthermia. Individual muscle weights, muscle gene expression, body composition and cardiac function were measured in rats bearing the Yoshida AH-130 ascites hepatoma, following theophylline treatment. Results: Theophylline treatment inhibited proteolysis in C2C12 cell line and resulted in an anti-proteolytic effect on muscle tissue (soleus and heart), which was associated with a decrease in circulating TNF-alpha levels and with a decreased proteolytic systems gene expression. Treatment with the nutraceutical also resulted in an improvement in body composition and cardiac function. Conclusion: Theophylline - alone or in combination with drugs - may be a candidate molecule for the treatment of cancer cachexia. | - |
dc.format.extent | 8 p. | - |
dc.format.mimetype | application/pdf | - |
dc.language.iso | eng | - |
dc.publisher | BioMed Central | - |
dc.relation.isformatof | Reproducció del document publicat a: https://doi.org/10.1186/1743-7075-9-76 | - |
dc.relation.ispartof | Nutrition and Metabolism, 2012, vol. 9, num. 1, p. 76 | - |
dc.relation.uri | https://doi.org/10.1186/1743-7075-9-76 | - |
dc.rights | cc-by (c) Olivan Riera, Mireia et al., 2012 | - |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/es | - |
dc.source | Articles publicats en revistes (Patologia i Terapèutica Experimental) | - |
dc.subject.classification | Teofil·lina | - |
dc.subject.classification | Caquèxia | - |
dc.subject.classification | Ratolins (Animals de laboratori) | - |
dc.subject.other | Theophylline | - |
dc.subject.other | Cachexia | - |
dc.subject.other | Mice (Laboratory animals) | - |
dc.title | Theophylline is able to partially revert cachexia in tumour-bearing rats | - |
dc.type | info:eu-repo/semantics/article | - |
dc.type | info:eu-repo/semantics/publishedVersion | - |
dc.identifier.idgrec | 620454 | - |
dc.date.updated | 2020-07-08T12:30:01Z | - |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | - |
dc.identifier.pmid | 22909172 | - |
Appears in Collections: | Articles publicats en revistes (Patologia i Terapèutica Experimental) Articles publicats en revistes (Bioquímica i Biomedicina Molecular) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
620454.pdf | 434.54 kB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License